Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Cancer research institute
Sep 29, 2023, 18:30 |
Blog
Vivek Subbiah: Thanks to Ishwaria Subbiah for discussing this crucial topic with the US Social Security Administration.
Vivek Subbiah shared a post by Ishwaria Subbiah on LinkedIn, adding: ''Cancer is the 2nd…
Sep 28, 2023, 20:32 |
Blog
Vivek Subbiah: So much enthusiasm for delivering Precision Medicine every where.
Vivek Subbiah, made the following post on LinkedIn: "Delighted to visit Park City, Utah to deliver…
Sep 28, 2023, 15:04 |
Dialogues
OncoDaily Dialogues #1 - Harout Semerjian / Hosted by Roupen Odabashian
We're thrilled to launch our new series, "OncoDaily Dialogues". This initiative by OncoDaily is designed…
Sep 27, 2023, 17:12 |
Opinion
Rasha Aboelhassan: Even if we did not win today, the next generation will.
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post by National Cancer Institute…
Sep 26, 2023, 18:01 |
Blog
Ishwaria Subbiah: Such a pleasure to help kickoff the Texas Society of Clinical Oncology’s 2023 Annual Meeting.
Ishwaria Subbiah shared the following on LinkedIn: ''Such a pleasure to help kickoff the Texas Society…
Sep 25, 2023, 15:11 |
Blog
Erika Hamilton: ASCO Plenary Series allows you the opportunity to present your data globally within 2 months of submission!
Erika Hamilton, shared the following on LinkedIn: "ASCO Plenary Series allows you the opportunity to…
Sep 23, 2023, 15:55 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 5
A month ago, OncoDaily began its series on '100 Influential Women in Oncology: Key Opinion…
Sep 21, 2023, 19:49 |
Blog
Vivek Subbiah: Super thrilled to discuss how to overcome tumor plasticity in the clinic and how can we design clinical trials with customized combinations to overcome this.
Sep 21, 2023, 18:12 |
Insight
Fiona Hamilton Marshall: These are hopeful findings for patients with relapsed/refractory diffuse large B-cell lymphomawho may not have a durable response to existing therapies.
Sep 21, 2023, 04:05 |
Drugs
Paolo Tarantino: The longest follow up to date of a metastatic trastuzumab trial.
Paolo Tarantino, a clinical research fellow at the Dana-Farber Cancer Institute, shared the following insight…
274
275
276
277
278
All:
2816
Posts:
2751 - 2760
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube